Related Experiment Videos
Discovery of potent, nonsteroidal, and highly selective glucocorticoid receptor antagonists
Bradley P Morgan1, Andrew G Swick, Diane M Hargrove
1Pfizer Global Research and Development, Pfizer Inc., Eastern Point Road, Groton, CT 06371, USA. bmorgan@cytokinetics.com
Journal of Medicinal Chemistry
|May 31, 2002
Abstract:
An approach to the computer-assisted, pharmacophore design of nonsteroidal templates for the glucocorticoid receptor (GR) that contained an element of pseudo-C2 symmetry was developed. The enatiomer of the initial design, 1Ra, and not the designed molecule, 1S, showed the desired ligand binding to the GR. The pseudo-C2 symmetry of the template allowed for rapid improvements in GR activity resulting in potent, selective, nonsteroidal GR antagonists, CP-394531 and CP-409069.